Enrollment Goals Exceeded Through High Touch, High Tech For A Dermatology Study Of Adolescent Patients

UBC was selected by a large biopharmaceutical company to manage a U.S. - based Phase IV randomized, placebo controlled clinical trial of patients with severe acne. The study included 284 patients, ages 9-11 years. Continue reading to see how as a result of UBC’s innovative services, not only was the enrollment goal achieved, but it was exceeded by 60%.